If you have some or all of these risk factors, will your insurance cover a breast reduction procedure, which the researchers say will reduce your breast cancer risk?
如果你有上面所说的部分或全部因素，就去为缩胸手术投保？就因为研究人员说缩胸可以降低患乳癌的风险？
Dr Viel, who admits breast augmentation is his favourite procedure, steps back to admire his work.
维尔医生承认，隆胸是他最喜欢做的手术，他后退一步欣赏刚刚出于自己之手的杰作。
So Bobbie Saunders was relieved when her doctor offered to perform the less radical procedure when she was diagnosed with breast cancer eight years ago.
因此，8年前，当医生告诉乳癌患者博比·桑德斯，准备为她做比较简单的手术时，她如释重负。
Australia's National breast and Ovarian cancer Center said the new procedure, if successful, would be in an important step forward in dealing with breast cancer.
澳大利亚国家乳腺癌和卵巢癌防治中心称如果新的治疗方法一旦成功，将会对乳腺癌的处理推进一大步。
The researchers insist that this lower mortality rate is not the result of the breast augmentation procedure itself, but rather of a double selection bias.
研究人员认为，这一较低的死亡率不是隆胸本身的结果，而是由于双重选择偏倚。
Methods: 9 patients with pathologically confirmed high risk breast cancer, lymphoma, and small cell lung cancer, previously treated with chemotherapy were treated with this procedure.
方法：9例经病理确诊的高危乳腺癌、淋巴瘤及小细胞肺癌在经不同程度的化疗后，进行了大剂量化疗并自体外周血干细胞的移植。
According to the American Society of Plastic Surgeons, breast augmentation is the third most commonly performed cosmetic surgical procedure in the United States.
据美国整形外科学会、隆胸手术最常见的是第三美容手术在美国。
She has recently had even larger breast implants fitted and her next procedure promises to be her most extreme yet as she plans to undergo height lengthening surgery.
为更接近愿望，最近她接受了进一步的隆胸手术。她下一步计划进行增高手术，这将是所有整形手术中最极端的一项。
Sentinel lymph node biopsy SLN is the standard procedure for axillary staging in patients with primary operable breast cancer and uninvolved axillary nodes.
前哨淋巴结活检是判断早期乳腺癌病人腋下分期的一项常规(标准)的做法，这类病人尚有未被侵袭的腋下淋巴结并可通过手术进行治疗。
The lead investigator, Dr. Keizo Sugimachi, reported Saturday at the San Antonio Breast Cancer Symposium that the procedure was safe and well-tolerated in all 21 subjects, with no signs of rejection.
首席研究员Keizo Sugimachi博士于星期六在SanAntonio乳腺癌研讨会上报道，该操作安全，21例所有受试对象都良好耐受，没有排斥反应征象。
The lead investigator, Dr. Keizo Sugimachi, reported Saturday at the San Antonio Breast Cancer Symposium that the procedure was safe and well-tolerated in all 21 subjects, with no signs of rejection.
首席研究员Keizo Sugimachi博士于星期六在SanAntonio乳腺癌研讨会上报道，该操作安全，21例所有受试对象都良好耐受，没有排斥反应征象。
应用推荐